A double-blind randomized placebo-controlled study comparing Epanova and fenofibrate on liver fat in overweight subjects.

Trial Identifier: D5881C00007
Sponsor: AstraZeneca
NCTID:: NCT02354976
Start Date: September 2015
Primary Completion Date: May 2016
Study Completion Date: May 2016
Condition: Heart, Blood & Circulatory - Other; Fatty Liver Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Sweden Göteborg, Sweden, 413 45
Sweden Malmö, Sweden, 205 02
Sweden Stockholm, Sweden, 11324
Sweden Uppsala, Sweden, 75237